Try our beta test site

Safety and Immunogenicity Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

This study has been completed.
Sponsor:
Information provided by:
Nanotherapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT00349141
First received: July 5, 2006
Last updated: October 7, 2015
Last verified: October 2007